Afroway Pharma Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Afroway Pharma Pharmaceutical Export Portfolio Dataset — 4 Products, $27.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Afroway Pharma — Pharmaceutical Exporter Profile (2026) | 4 Products, $27.0M Trade | TransData Nexus

Product Portfolio — Top 4 by Export Value

Afroway Pharma exports 4 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Artesunate	Antimalarial & Antiparasitic	$15.9M	336	9.2%	2
2	Artemether	Antimalarial & Antiparasitic	$8.6M	171	1.0%	6
3	Kit	Medical Devices & Diagnostics	$1.9M	37	0.4%	11
4	Lansoprazole	Gastrointestinal	$750.0K	15	0.3%	11

Afroway Pharma exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $27.0M. The top category is Antimalarial & Antiparasitic (90.4% of portfolio), followed by Medical Devices & Diagnostics (6.8%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Afroway Pharma — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Afroway Pharma is an Indian pharmaceutical manufacturer and exporter specializing in a comprehensive range of high-quality finished pharmaceutical formulations, including tablets, capsules, syrups, injections, ointments, and nutraceuticals. Established on November 1, 2020, as a partnership firm, the company is headquartered in Ahmedabad, Gujarat, India.

The firm's registered office is located at D-412, Sumel-11, Indian Textile Plaza, Near Namaste Circle, Shahibaug, Ahmedabad-380004, Gujarat, India.

Afroway Pharma is classified as a small enterprise under the MSME (Micro, Small, and Medium Enterprises) category for the financial year 2024-25.

2Manufacturing Facilities

Afroway Pharma operates a WHO-GMP certified manufacturing facility in Ahmedabad, Gujarat, India.

3Key Leadership

Specific details regarding the CEO, CFO, and other key executives of Afroway Pharma are not publicly disclosed.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Afroway Pharma Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Afroway Pharma's products are available in several African countries, including South Sudan, Somalia, and Angola.

2Emerging Markets

Afroway Pharma has expanded its presence in emerging markets, particularly in Africa, with products available in countries such as South Sudan, Somalia, and Angola.

3Geographic Strategy

Afroway Pharma's geographic strategy focuses on expanding its footprint in emerging markets, particularly in Africa, to diversify its market presence and reduce dependence on any single region.

TransData Nexus Research · FDA, EMA, WHO, MHRA, TGA databasesMar 2026

Afroway Pharma — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Afroway Pharma's FDA facility registrations, approved ANDAs, DMF filings, and inspection history is not publicly available.

2WHO & EU GMP

Afroway Pharma's manufacturing facility is WHO-GMP certified, ensuring compliance with international quality standards.

3CDSCO & Indian Regulatory

Afroway Pharma holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and complies with state drug controller approvals and export NOCs, adhering to Indian regulatory requirements.

4Recent Regulatory Actions

No specific information regarding recent regulatory actions, such as Form 483 observations, warning letters, or import alerts, is publicly available for Afroway Pharma.

Afroway Pharma — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Afroway Pharma operates in a competitive landscape with numerous pharmaceutical manufacturers and exporters. While specific competitors are not identified, the company's focus on high-quality finished formulations positions it in competition with both domestic and international players in the pharmaceutical export market.

2Key Differentiators

Afroway Pharma's key differentiators include its commitment to quality, as evidenced by its WHO-GMP certified manufacturing facility, and its diverse product portfolio encompassing tablets, capsules, syrups, injections, ointments, and nutraceuticals.

3Strategic Position

Afroway Pharma's current strategic direction emphasizes expanding its presence in emerging markets, particularly in Africa, to diversify its market reach and reduce dependence on any single region. The company's future outlook includes further strengthening its position in the global pharmaceutical export market.

TransData Nexus Research · DGFT export records, industry analysis

Buyer Due Diligence Brief — Evaluating Afroway Pharma as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Afroway Pharma has demonstrated a consistent track record in exporting pharmaceutical products, with a total export value of $27.0 million USD and 559 shipments across 4 products in 3 therapeutic categories. The company's reliability is indicated by its WHO-GMP certified manufacturing facility and adherence to international quality standards.

2Certifications to Verify

Importers should verify the following certifications when considering Afroway Pharma as a supplier:

WHO-GMP Certification: Ensures compliance with international manufacturing standards. Verification can be done by requesting a copy of the certificate from Afroway Pharma or checking with the World Health Organization's official records.

3Due Diligence Checklist

When conducting due diligence on Afroway Pharma, consider the following steps:

Frequently Asked Questions — Afroway Pharma

How many pharmaceutical products does Afroway Pharma export from India?

Afroway Pharma exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Artesunate ($15.9M), Artemether ($8.6M), Kit ($1.9M), Lansoprazole ($750.0K). Total export value is $27.0M.

What is Afroway Pharma's total pharmaceutical export value?

Afroway Pharma's total pharmaceutical export value is $27.0M, based on 559 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Afroway Pharma cover?

Afroway Pharma exports across 3 therapeutic categories. The largest are Antimalarial & Antiparasitic (90.4%, 2 products), Medical Devices & Diagnostics (6.8%, 1 products), Gastrointestinal (2.8%, 1 products).

Get Full Afroway Pharma Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Afroway Pharma

Afroway Pharma — Export Portfolio & Destination Treemap

Who is Afroway Pharma? — Company Overview & Market Position

What Does Afroway Pharma Export? — Product Portfolio Analysis

Top Products by Export Value

Afroway Pharma Therapeutic Categories — 3 Specializations